Increased alcohol consumption in Urocortin 3 knockout mice is unaffected by chronic inflammatory pain

Alcohol and Alcoholism

Volumn 50, Issue 2, 2015, Pages 132-139

  Smith, Monique L ^a   Li, Ju ^a   Ryabinin, Andrey E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; UROCORTIN III; UCN3 PROTEIN, MOUSE; UROCORTIN;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC INFLAMMATORY PAIN; COMPARATIVE STUDY; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; FLUID INTAKE; GENOTYPE; KNOCKOUT MOUSE; MALE; MECHANICAL STIMULUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROCEDURES; ANIMAL; ANIMAL BEHAVIOR; CHRONIC PAIN; DECISION MAKING; GENETICS; INFLAMMATION; MENTAL STRESS; METABOLISM; PSYCHOLOGY;

MUS; RODENTIA;

ALCOHOL DRINKING; ANIMALS; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; CHRONIC PAIN; FEMALE; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; STRESS, PSYCHOLOGICAL; UROCORTINS;

EID: 84936067806     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agu084     Document Type: Article

References (55)

1. Angst MS, Clark JD. (2006) Opioid-induced hyperalgesia: a qualitative systematic review. Anesthes 104:570-87.
2. Belknap JK, Crabbe JC, Young ER. (1993) Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology 112:503-10.
3. Breese GR, Sinha R, Heilig M. (2011) Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol Ther 129:149-71.
4. Brennan PL, Schutte KK, Moos RH. (2005) Pain and use of alcohol to manage pain: prevalence and 3-year outcomes among older problem and non-problem drinkers. Addiction 100:777-86.
5. Chaplan SR, Bach FW, Pogrel JW et al. (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Meth 53:55-63.
6. Chillingworth NL, Donaldson LF. (2003) Characterisation of a Freund's complete adjuvant-induced model of chronic arthritis in mice. J Neurosci Meth 128:45-52.
7. Collins AC, Yeager TN, Lebsack ME et al. (1975) Variations in alcohol metabolism: influence of sex and age. Pharmacol Biochem Behav 3:973-8.
8. Crabbe JC. (1989) Genetic animal models in the study of alcoholism. Alcohol Clin Exp Res 13:120-7.
9. Deussing JM, Breu J, Kühne C et al. (2010) Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. J Neurosci 30:9103-16.
10. Edwards S, Koob GF. (2010) Neurobiology of dysregulated motivational systems in drug addiction. Future Neurol 5:393-401.
11. Edwards S, Vendruscolo LF, Schlosburg JE et al. (2012) Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF1 receptor antagonism. Neuropharmacology 62:1142-51.
12. Egli M, Koob GF, Edwards S. (2012) Alcohol dependence as a chronic pain disorder. Neurosci Biobehav Rev 36:2179-92.
13. Fu Y, Neugebauer V. (2008) Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J Neurosci 28:3861-76.
14. Funk CK, Koob GF. (2007) A CRF2 agonist administered into the central nucleus of the amygdala decreases ethanol selfadministration in ethanol-dependent rats. Brain Res 1155:172-8.
15. Funk CK, O'Dell LE, Crawford EF et al. (2006) Corticotropinreleasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 26:11324-32.
16. Gatch MB. (1999) Effects of benzodiazepines on acute and chronic ethanol-induced nociception in rats. Alcohol Clin Exp Res 23:1736-43.
17. Gatch MB. (2006) Tolerance to the antinociceptive effects of ethanol during ethanol withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 30:946-52.
18. Gatch MB. (2009) Ethanol withdrawal and hyperalgesia. Curr Drug Abuse Rev 2:41-50.
19. Gatch MB, Lal H. (1999) Effects of ethanol and ethanol withdrawal on nociception in rats. Alcohol Clin Exp Res 23:328-33.
20. Gianoulakis C, Dai X, Brown T. (2003) Effect of chronic alcohol consumption on the activity of the hypothalamic-pituitary-adrenal axis and pituitary beta-endorphin as a function of alcohol intake, age, and gender. Alcohol Clin Exp Res 27:410-23.
21. Giardino WJ, Ryabinin AE. (2012) Corticotropin-releasing factor: innocent until proven guilty. Nat Rev Neurosci 13:70.
22. Giardino WJ, Cocking DL, Kaur S et al. (2011) Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference. PLoS One 6:e26997.
23. Goldberg RT, Pachas WN, Keith D. (1999) Relationship between traumatic events in childhood and chronic pain. Disabil Rehabil 21:23-30.
24. Gravanis A, Margioris A. (2005) The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. Curr Med Chem 12:1503-12.
25. Heilig M, Koob GF. (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30:399-406.
26. James M, Duthie AM, Duffy BL. (1978) Analgesic effect of ethyl alcohol. Br J Anaesth 50:139-41.
27. Janssen D, Kozicz T. (2013) Is it really a matter of simple dualism? Corticotropin-releasing factor receptors in body and mental health. Front Endocrinol 4:28.
28. Ji G, Neugebauer V. (2008) Pro-and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors. J Neurophysiol 99: 1201-12.
29. Ji G, Fu Y, Ruppert KA et al. (2007) Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain 3:13.
30. Jørgensen HA, Hole K. (1984) Learned tolerance to ethanol in the spinal cord. Pharmacol Biochem Behav 20:789-92.
31. Katon W, Egan K, Miller D. (1985) Chronic pain: lifetime psychiatric diagnoses. Am J Psychiatry 142:1156-60.
32. Koob GF. (2013) Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. Curr Top Behav Neurosci 13:3-30.
33. Lee M, Silverman SM, Hansen H et al. (2011) A comprehensive review of opioid-induced hyperalgesia. Pain Physician 14:145-61.
34. Lewis K, Li C, Perrin MH et al. (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570-5.
35. Li C, Vaughan J, Sawchenko PE et al. (2002) Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 22:991-1001.
36. Li C, Chen P, Vaughan J et al. (2007) Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis. Proc Natl Acad Sci U S A 104:4206-11.
37. Lowery E.G., Spanos M, Navarro M et al. (2010) CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology 35:1241-52.
38. Lu Y, Sun Y-N, Wu X et al. (2008) Role of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluR1 in spinal dorsal horn in inflammatory nociception and neuropathic nociception in rat. Brain Res 1200:19-26.
39. Millan MJ, Członkowski A, Morris B et al. (1988) Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat. Pain 35:299-312.
40. McNally GP, Akil H. (2002) Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. Neuroscience 112:605-17.
41. Novembri R, Carrarelli P, Toti P et al. (2011) Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response. Mol Hum Reprod 17:587-93.
42. Pérez-García S, Juarranz Y, Carrión M et al. (2011) Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: effect of vasoactive intestinal peptide. J Cell Physiol 226:3261-9.
43. Ren K, Dubner R. (1999) Inflammatory models of pain and hyperalgesia. ILAR J 40:111-8.
44. Reyes TM, Lewis K, Perrin MH et al. (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843-8.
45. Riley JL, III, King C. (2009) Self-report of alcohol use for pain in a multi-ethnic community sample. J Pain 10:944-52.
46. Rouwette T, Vanelderen P, Roubos EW et al. (2012) The amygdala, a relay station for switching on and off pain. Eur J Pain 16:782-92.
47. Ryabinin AE, Tsoory MM, Kozicz T et al. (2012) Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior. Alcohol 46:349-57.
48. Saddler JM, James MF, Harington AP. (1985) Naloxone does not reverse ethanol analgesia in man. Clin Exp Pharmacol Physiol 12: 359-64.
49. Sharpe AL, Phillips TJ. (2009) Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice. Behav Pharmacol 20:346-51.
50. Stewart SH, Finn PR, Pihl RO. (1995) A dose-response study of the effects of alcohol on the perceptions of pain and discomfort due to electric shock in men at high familial-genetic risk for alcoholism. Psychopharmacology 119:261-7.
51. Tiffany ST, McCal KJ, Maude-Griffin PM. (1987) The contribution of classical conditioning to tolerance to the antinociceptive effects of ethanol. Psychopharmacology 92:524-8.
52. Wittmann G, Füzesi T, Liposits Z. (2009) Distribution and axonal projections of neurons coexpressing thyrotropin-releasing hormone and urocortin 3 in the rat brain. J Comp Neurol 517:825-40.
53. Woodrow KM, Eltherington LG. (1988) Feeling no pain: alcohol as an analgesic. Pain 32:159-63.
54. Yoneyama N, Crabbe JC, Ford MM et al. (2008) Voluntary ethanol consumption in 22 inbred mouse strains. Alcohol 42:149-60.
55. Zorrilla EP, Logrip ML, Koob GF. (2014) Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol 35:234-44.